The coronavirus disease 2019 (COVID-19) was a global endemic that continues to cause a
large number of severe illnesses and fatalities. There is increasing evidence that non-coding …

The recently developed pathogenic virus, SARS-CoV-2, was found in the Hubei Province,
China. Giving rise to a broad spectrum of symptoms, SARS-CoV-2 rapidly spread across the …

Coronavirus disease 2019 (COVID-19), which has high incidence rates with rapid rate of
transmission, is a pandemic that spread across the world, resulting in more than 3,000,000 …

Background: In 2019, the coronavirus pandemic emerged, resulting in the highest mortality
and morbidity rate globally. It has a prevailing transmission rate and continues to be a global …

Viral infections present significant challenges to human health, underscoring the importance
of understanding the immune response for effective therapeutic strategies. Immune cell …

Simple Summary Advances in RNA sequencing (RNA-seq) have led to the identification of
long non-coding RNAs (lncRNAs). Molecular studies on these molecules have shown that …

Rationale: Viral infections are complex processes based on an intricate network of
molecular interactions. The infectious agent hijacks components of the cellular machinery for …

Long noncoding RNAs (lncRNAs) are transcripts measuring> 200 bp in length and devoid of
protein-coding potential. LncRNAs exceed the number of protein-coding mRNAs and …

Some recent studies showed that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infections and idiopathic pulmonary fibrosis (IPF) disease might stimulate each other …

Since the end of 2019, COVID-19 caused by SARS-CoV-2 has spread worldwide, and the
understanding of the new coronavirus is in a preliminary stage. Currently, immunotherapy …